PER 5.13% 7.4¢ percheron therapeutics limited

Ann: Updated Company Presentation, page-2

  1. 35,729 Posts.
    lightbulb Created with Sketch. 554
    Nice re-release of the old company presentation - can't see anything different aside from 50% patient enrolment as released the other day ?

    Has the lagging dates out to Q3 for final dosing on slower than expected enrolment but that was expected for a long time - still get the feeling it could end up 50/50 that it actually goes out to Q4 with them still needing to find another 2 patients followed by prep and then 6 months dosing - should def get at least preliminary data Q3 imo . Always hard to make recruitment numbers in rare diseases hence why they get such small numbers required for trials.

    Not sure about 1103 Acromegaly EA hard to read when that will materialise it's been stalled for a while.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.4¢
Change
-0.004(5.13%)
Mkt cap ! $66.71M
Open High Low Value Volume
7.8¢ 7.8¢ 7.2¢ $78.26K 1.049M

Buyers (Bids)

No. Vol. Price($)
1 5919 7.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 156164 2
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.